{
     "PMID": "3378575",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "19880715",
     "LR": "20151119",
     "IS": "0014-2999 (Print) 0014-2999 (Linking)",
     "VI": "148",
     "IP": "2",
     "DP": "1988 Mar 29",
     "TI": "Omega-conotoxin GVIA and pharmacological modulation of hippocampal noradrenaline release.",
     "PG": "261-7",
     "AB": "The tritium overflow evoked by electrical stimulation of rabbit hippocampal slices labeled with [3H]noradrenaline was inhibited by omega-conotoxin GVIA, a peptide modulator of the N-type voltage-sensitive calcium channel (N-VSCC). The magnitude of this inhibition was unchanged in the presence of substances which interact with N- and/or L-VSCCs (cadmium, neomycin, (-)- and (+)-202-791), alpha 2-adrenoceptors (idazoxan, UK-14304), protein kinase C (4 beta-phorbol-12,13-dibutyrate) or potassium channels (4-aminopyridine). This finding suggests that the attenuation of calcium-dependent neurotransmitter release by omega-conotoxin GVIA is relatively insensitive to alterations of such release effected by other substances.",
     "FAU": [
          "Dooley, D J",
          "Lupp, A",
          "Hertting, G",
          "Osswald, H"
     ],
     "AU": [
          "Dooley DJ",
          "Lupp A",
          "Hertting G",
          "Osswald H"
     ],
     "AD": "Godecke Research Institute, Freiburg, F.R.G.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "Netherlands",
     "TA": "Eur J Pharmacol",
     "JT": "European journal of pharmacology",
     "JID": "1254354",
     "RN": [
          "0 (Aminopyridines)",
          "0 (Calcium Channel Blockers)",
          "0 (Dioxanes)",
          "0 (Mollusk Venoms)",
          "0 (Nicotinic Acids)",
          "0 (Oxadiazoles)",
          "0 (Phorbol Esters)",
          "0 (Quinoxalines)",
          "00BH33GNGH (Cadmium)",
          "101342-80-7 (PN 202-791)",
          "1404-04-2 (Neomycin)",
          "4S9CL2DY2H (Brimonidine Tartrate)",
          "92078-76-7 (omega-Conotoxin GVIA)",
          "X4W3ENH1CV (Norepinephrine)",
          "Y310PA316B (Idazoxan)"
     ],
     "SB": "IM",
     "MH": [
          "Aminopyridines/pharmacology",
          "Animals",
          "Brimonidine Tartrate",
          "Cadmium/pharmacology",
          "Calcium Channel Blockers/*pharmacology",
          "Dioxanes/pharmacology",
          "Hippocampus/drug effects/*metabolism",
          "Idazoxan",
          "In Vitro Techniques",
          "Mollusk Venoms/*pharmacology",
          "Neomycin/pharmacology",
          "Nicotinic Acids/pharmacology",
          "Norepinephrine/*secretion",
          "*Oxadiazoles",
          "Phorbol Esters/pharmacology",
          "Quinoxalines/pharmacology",
          "Rabbits",
          "omega-Conotoxin GVIA"
     ],
     "EDAT": "1988/03/29 00:00",
     "MHDA": "1988/03/29 00:01",
     "CRDT": [
          "1988/03/29 00:00"
     ],
     "PHST": [
          "1988/03/29 00:00 [pubmed]",
          "1988/03/29 00:01 [medline]",
          "1988/03/29 00:00 [entrez]"
     ],
     "AID": [
          "0014-2999(88)90572-9 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Eur J Pharmacol. 1988 Mar 29;148(2):261-7.",
     "term": "hippocampus"
}